The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics and clinical outcome of BRCA germline mutation carriers with advanced breast cancer treated with PARP (poly ADP-ribose polymerase) inhibitors: A single institution experience.
 
Fatma Nihan Akkoc Mustafayev
No Relationships to Disclose
 
Mark Munsell
No Relationships to Disclose
 
Angelica M. Gutierrez-Barrera
No Relationships to Disclose
 
Clinton Yam
Consulting or Advisory Role - Gilead Sciences
Research Funding - Amgen (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst)
 
Rachel M. Layman
Consulting or Advisory Role - Celcuity; GE Healthcare (I); Lilly; Novartis; Siemens (I)
Research Funding - Accutar Biotech; Celcuity; GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Zentalis (Inst)
(OPTIONAL) Uncompensated Relationships - Lilly
 
Banu Arun
Research Funding - AstraZeneca (Inst)